L Jay Katz
Overview
Explore the profile of L Jay Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh I, Voskanyan L, Barber K, Burden J, Connolly L, Katz L, et al.
Ther Adv Ophthalmol
. 2025 Feb;
17:25158414241310275.
PMID: 39959854
Background: The travoprost intracameral implant and cataract surgery both lower intraocular pressure (IOP). Objectives: We evaluated the safety and IOP-lowering effect at 3 months following administration of travoprost intracameral implant...
2.
Katz L, Myers J, Herndon L, Kresch Y, Hengerer F
Clin Ophthalmol
. 2024 Nov;
18:3365-3374.
PMID: 39588379
Glaucoma treatment is beginning to undergo an evolution, moving away from topical medication-based therapies toward more proactive minimally invasive interventions. This shift towards an "interventional glaucoma" treatment paradigm has been...
3.
Singh I, Berdahl J, Sarkisian Jr S, Voskanyan L, Ang R, Doan L, et al.
Drugs
. 2024 Sep;
84(10):1299-1311.
PMID: 39240530
Aim: The purpose of this study was to conduct and interpret a pooled 12-month analysis of two prospective, multi-center, randomized, double-masked, controlled trials designed to assess the efficacy and safety...
4.
Bacharach J, Doan L, Stephens K, Usner D, Kothe A, Katz L, et al.
Ophthalmol Ther
. 2024 Jul;
13(9):2357-2367.
PMID: 38985408
Introduction: This study was conducted to analyze and compare the intraocular pressure (IOP) treatment effect of the slow-eluting (SE) travoprost intracameral implant to the IOP treatment effect of topical prostaglandin...
5.
Shalaby W, Reddy R, Razeghinejad R, Katz L
J Ophthalmic Vis Res
. 2024 Apr;
19(1):88-108.
PMID: 38638634
Glaucoma is the leading cause of irreversible blindness worldwide. Among all glaucoma types, primary angle closure glaucoma (PACG) affects approximately 23 million people worldwide, and is responsible for 50% of...
6.
Hallaj S, Sinha S, Mehran N, Morrill A, Pro M, Dale E, et al.
Eur J Ophthalmol
. 2024 Mar;
34(6):1957-1963.
PMID: 38470322
Purpose: To compare the intraocular pressure (IOP) profile and the incidence of IOP spikes following selective laser trabeculoplasty (SLT) between pigmentary glaucoma (PG) and primary open-angle glaucoma (POAG). Materials And...
7.
Sarkisian Jr S, Ang R, Lee A, Berdahl J, Heersink S, Burden J, et al.
Ophthalmology
. 2024 Feb;
131(9):1021-1032.
PMID: 38423216
Purpose: To evaluate the safety and intraocular pressure (IOP)-lowering efficacy of 2 models of the travoprost intraocular implant (fast-eluting [FE] and slow-eluting [SE] types) from 1 of 2 phase 3...
8.
Sarkisian S, Ang R, Lee A, Berdahl J, Heersink S, Burden J, et al.
Ophthalmol Ther
. 2024 Feb;
13(4):995-1014.
PMID: 38345710
Introduction: This prospective, multicenter, randomized, double-masked pivotal phase 3 trial evaluated the efficacy and safety of the travoprost intracameral SE-implant (slow-eluting implant, the intended commercial product) and FE-implant (fast-eluting implant,...
9.
Berdahl J, Sarkisian Jr S, Ang R, Doan L, Kothe A, Usner D, et al.
Drugs
. 2023 Dec;
84(1):83-97.
PMID: 38060092
Purpose: A randomized, double-masked, multicenter, phase 2 trial to evaluate the long-term safety and efficacy of travoprost intraocular implant, an extended-release drug delivery system designed to provide uninterrupted sustained intraocular...
10.
A Proposal for the Use of a Fixed Low-Energy Selective Laser Trabeculoplasty for Open Angle Glaucoma
Sacks Z, Katz L, Gazzard G, Van Tassel S, Blumenthal E, Lerner F, et al.
J Glaucoma
. 2023 Oct;
33(1):1-7.
PMID: 37851966
Selective laser trabeculoplasty (SLT) has been in routine clinical use for over 20 years with millions of patients successfully treated and a low rate of clinically significant complications. The procedure...